These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 14521119)
1. One pill fits all. Naish J Nurs Stand; 2003 Aug 27-Sep 2; 17(50):17. PubMed ID: 14521119 [No Abstract] [Full Text] [Related]
2. Reflections on the regulation of the Polypill. Forslund L Nat Clin Pract Cardiovasc Med; 2009 Feb; 6(2):94-5. PubMed ID: 19047991 [No Abstract] [Full Text] [Related]
3. Panacea in a pill? Amsterdam EA Prev Cardiol; 2004; 7(1):46-7. PubMed ID: 15010628 [No Abstract] [Full Text] [Related]
4. Polypill: Can its Potential Enhancement of Efficacy Trigger New Interest? Chao J; Bansilal S Glob Heart; 2016 Dec; 11(4):469-472. PubMed ID: 27938845 [No Abstract] [Full Text] [Related]
5. The Polypill in the prevention of cardiovascular disease. Wald DS; Wald NJ Prev Med; 2011 Jan; 52(1):16-7. PubMed ID: 21130112 [No Abstract] [Full Text] [Related]
6. Doubts surround study results touting polypill's benefits. The experimental pill contains four heart medications. Heart Advis; 2011 Aug; 14(8):4. PubMed ID: 23097801 [No Abstract] [Full Text] [Related]
7. News of the polypill. Marshall T BMJ; 2008 Oct; 337():a2160. PubMed ID: 18936068 [No Abstract] [Full Text] [Related]
8. [The polypill: optimal strategy for reduction of cardiovascular disease]. Nathoe HM; Doevendans PA Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1740. PubMed ID: 16114290 [TBL] [Abstract][Full Text] [Related]
9. Embracing the polypill as a cardiovascular therapeutic: is this the best strategy? Franczyk B; Gluba-Brzózka A; Jurkiewicz Ł; Penson P; Banach M; Rysz J Expert Opin Pharmacother; 2018 Dec; 19(17):1857-1865. PubMed ID: 30295098 [TBL] [Abstract][Full Text] [Related]
10. "Polypill-aspostatinoprilololazide folate"--coprescription for at the risk Asian Indian in chronic non communicable diseases. Joshi SR J Assoc Physicians India; 2005 Mar; 53():175-8. PubMed ID: 15926597 [No Abstract] [Full Text] [Related]
11. [The polypill: not an effective strategy for reduction of cardiovascular disease]. Westerweel PE; van Wijk JP; Verhaar MC Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1741. PubMed ID: 16114291 [TBL] [Abstract][Full Text] [Related]
12. The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study. Xavier D; Pais P; Sigamani A; Pogue J; Afzal R; Yusuf S; Nat Clin Pract Cardiovasc Med; 2009 Feb; 6(2):96-7. PubMed ID: 19104516 [No Abstract] [Full Text] [Related]
13. [The Polypill - A Practicable Approach?]. Thürmann PA; Kleinerüschkamp AG; Boehme P Dtsch Med Wochenschr; 2019 Jun; 144(11):715-718. PubMed ID: 31163467 [TBL] [Abstract][Full Text] [Related]
14. Benefits, challenges, and registerability of the polypill. Sleight P; Pouleur H; Zannad F Eur Heart J; 2006 Jul; 27(14):1651-6. PubMed ID: 16603580 [TBL] [Abstract][Full Text] [Related]
16. [Cardiovascular disease in those aged 55 years and over controlled with a combined pill against 4 risk factors: some brief comments]. Rabelink TJ Ned Tijdschr Geneeskd; 2003 Aug; 147(32):1537-8. PubMed ID: 12942841 [TBL] [Abstract][Full Text] [Related]
17. A single pill for prevention? Harv Heart Lett; 2009 Jul; 19(11):6. PubMed ID: 19927382 [No Abstract] [Full Text] [Related]
18. Prospects and possible pitfalls of a preventive Polypill: confessions of a health promotion convert. Green LW Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S4-8; discussion S9. PubMed ID: 16052194 [TBL] [Abstract][Full Text] [Related]
19. Combination therapy to prevent cardiovascular disease: slow progress. Smith R; McCready T; Yusuf S JAMA; 2013 Apr; 309(15):1595-6. PubMed ID: 23529576 [No Abstract] [Full Text] [Related]
20. It takes more than statins to keep cholesterol under control. Research shows that many patients on statin therapy still aren't reaching their LDL cholesterol targets. Heart Advis; 2009 Dec; 12(12):5. PubMed ID: 21189515 [No Abstract] [Full Text] [Related] [Next] [New Search]